+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mobile In-Home NAD IV Therapy Market - Global Forecast 2026-2032- Product Image
Mobile In-Home NAD IV Therapy Market - Global Forecast 2026-2032- Product Image
New

Mobile In-Home NAD IV Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122864
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mobile in-home NAD IV therapy market is advancing quickly, moving toward an integrated, clinically governed model that prioritizes trust, convenience, and operational scalability for both providers and patients.

Market Snapshot: Mobile In-Home NAD IV Therapy Market

In 2025, the mobile in-home NAD IV therapy market was valued at USD 128.21 million and is projected to reach USD 140.32 million in 2026, growing at a CAGR of 7.47%. This rapid growth is expected to bring the market to USD 212.34 million by 2032. Expansion is being driven by demand for convenient, premium care delivered directly to residences and workplaces, underpinned by clinical oversight and consumer trust.

Scope & Segmentation

This report covers the full mobile in-home NAD IV therapy ecosystem, focusing on the evolving interplay between concierge medicine, infusion services, and the at-home health consumer.

  • Service Types: Standalone NAD infusions, structured multi-visit programs, and bundled therapies with hydration or adjunct nutrients.
  • Delivery Contexts: Private residences, corporate offices, hotels, and short-term rentals, with tailored resource allocation and privacy protocols.
  • Customer Segments: Individuals seeking fatigue recovery, performance optimization, or ongoing wellness, and organizations such as employer wellness programs and fitness communities.
  • Technology Solutions: Digital platforms for scheduling, consent, triage, and documentation that enable consistent operations and audit trails.
  • Clinical Governance: Protocols emphasizing medical director oversight, eligibility screening, and quality documentation.
  • Regions: North America, South America, Europe, Middle East, Africa, and Asia-Pacific, each with unique regulatory, infrastructure, and market maturity profiles.

Key Takeaways

  • Customer expectations are shifting from basic convenience to demands for transparency, safety, and personalized experiences at home or work.
  • Providers must adapt operations to healthcare standards, supplying consistent protocols, documented consent, and scalable service design.
  • Digital workflow integration is critical; technology underpins dispatch optimization, inventory management, and compliance in unpredictable environments.
  • Talent shortages in IV-capable clinicians and regional regulatory differences require robust training, retention strategies, and programmatic escalation paths.
  • Partnerships—with telehealth, hospitality, employer benefits, and supply chain partners—are stabilizing demand and supporting trust.
  • Differentiation increasingly relies on visible medical governance and clinician-centric service models rather than marketing alone.

Tariff Impact on Supply Chain and Procurement

Recent U.S. tariff changes have added complexity to procurement, driving up landed costs for medical supplies, infusion disposables, packaging, and device components. Operators are responding by diversifying supply chains, qualifying secondary vendors, and expanding safety stocks to mitigate visit cancellations and protect patient trust. Larger networks are better positioned to absorb these shocks, while smaller providers are narrowing their protocol and product range to limit risk. Domestic sourcing is gaining traction, but thorough compliance and quality checks remain essential to maintain delivery standards.

Methodology & Data Sources

This report is based on structured stakeholder interviews, regulatory analysis, and product reviews that reflect real-world operations and decision-making. Value chain mapping and segmentation clarify the impact of compliance, risk management, and scalable workflows specific to mobile NAD IV therapy.

Why This Report Matters

  • Enables strategic growth by clarifying operational barriers and opportunities in the mobile in-home NAD IV therapy market.
  • Offers clear guidance on clinical safety, digital operations, and procurement resilience, tailored for executive leadership navigating evolving market dynamics.
  • Provides actionable insight into how regulatory trends, technology platforms, and partnerships shape competitive advantage globally.

Conclusion

The mobile in-home NAD IV therapy market is maturing, with success pivoting on operational consistency, resilient supply strategies, and trusted clinical standards. Providers who operationalize these factors at scale will be best positioned as the sector continues to evolve.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Mobile In-Home NAD IV Therapy Market, by Age Group
8.1. 18-34
8.2. 35-54
8.3. 55+
9. Mobile In-Home NAD IV Therapy Market, by Service Model
9.1. On-Demand
9.2. Subscription
9.2.1. Annual Plan
9.2.2. Monthly Plan
10. Mobile In-Home NAD IV Therapy Market, by Provider Type
10.1. Nurse Practitioner
10.2. Paramedic
10.3. Registered Nurse
11. Mobile In-Home NAD IV Therapy Market, by Pricing Tier
11.1. Economy
11.2. Premium
11.3. Standard
12. Mobile In-Home NAD IV Therapy Market, by Application
12.1. Addiction Recovery
12.2. Anti-Aging
12.3. Athletic Performance
12.4. Cognitive Enhancement
12.5. Wellness & Nutrition
13. Mobile In-Home NAD IV Therapy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Mobile In-Home NAD IV Therapy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Mobile In-Home NAD IV Therapy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Mobile In-Home NAD IV Therapy Market
17. China Mobile In-Home NAD IV Therapy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Azivmedics
18.6. BioReset Medical
18.7. Drip Hydration Inc.
18.8. Embark Health, LLC
18.9. GIV Wellness
18.10. HydraMed
18.11. Hydrate IV Bar, LLC
18.12. IV Boost UK
18.13. IVme Wellness + Performance, LLC
18.14. LIVV Natural
18.15. Mobile IV Drip
18.16. Mobile IV Medics Inc.
18.17. Modwella
18.18. Nadclinic
18.19. Premiumhealth
18.20. Pristine IV Hydration & Wellness, Inc.
18.21. Reset IV
18.22. Restore Hyper Wellness, Inc.
18.23. Rocky Mountain Ivmedics
18.24. Seaside Skin Care
18.25. The Hydration Lounge, LLC
18.26. The IV Doc, LLC
18.27. The Wellness Lab
18.28. Thedripclub
18.29. VitaSquad, Inc.
List of Figures
FIGURE 1. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 18-34, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 18-34, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 18-34, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 35-54, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 35-54, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 35-54, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 55+, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 55+, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY 55+, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ON-DEMAND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ON-DEMAND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANNUAL PLAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANNUAL PLAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANNUAL PLAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY MONTHLY PLAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY MONTHLY PLAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY MONTHLY PLAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY NURSE PRACTITIONER, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY NURSE PRACTITIONER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY NURSE PRACTITIONER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PARAMEDIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PARAMEDIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PARAMEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY REGISTERED NURSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY REGISTERED NURSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY REGISTERED NURSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ECONOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ECONOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ECONOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ADDICTION RECOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ADDICTION RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ADDICTION RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ATHLETIC PERFORMANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ATHLETIC PERFORMANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY ATHLETIC PERFORMANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY WELLNESS & NUTRITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY WELLNESS & NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY WELLNESS & NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 93. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 94. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 107. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 108. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 109. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 111. AFRICA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 122. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 123. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 124. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 126. ASEAN MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 130. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 131. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 132. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 133. GCC MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 144. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 145. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 147. BRICS MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 151. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 152. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 153. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 154. G7 MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 158. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 159. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 160. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 161. NATO MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 172. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 173. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY SUBSCRIPTION, 2018-2032 (USD MILLION)
TABLE 174. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
TABLE 175. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
TABLE 176. CHINA MOBILE IN-HOME NAD IV THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Mobile In-Home NAD IV Therapy market report include:
  • Azivmedics
  • BioReset Medical
  • Drip Hydration Inc.
  • Embark Health, LLC
  • GIV Wellness
  • HydraMed
  • Hydrate IV Bar, LLC
  • IV Boost UK
  • IVme Wellness + Performance, LLC
  • LIVV Natural
  • Mobile IV Drip
  • Mobile IV Medics Inc.
  • Modwella
  • Nadclinic
  • Premiumhealth
  • Pristine IV Hydration & Wellness, Inc.
  • Reset IV
  • Restore Hyper Wellness, Inc.
  • Rocky Mountain Ivmedics
  • Seaside Skin Care
  • The Hydration Lounge, LLC
  • The IV Doc, LLC
  • The Wellness Lab
  • Thedripclub
  • VitaSquad, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 140.32 Million
Forecasted Market Value ( USD ) by 2032 $ 212.34 Million
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F - Product Image

U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Pharmaceutical Sterile Fill-Finish - Global Strategic Business Report - Product Image

Pharmaceutical Sterile Fill-Finish - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
NAD+ IV Therapy Market - Global Forecast 2026-2032 - Product Image

NAD+ IV Therapy Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.